Stay updated on Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical trial record for nivolumab with FOLFOX after chemoradiation in locally advanced rectal cancer is now displayed, including the study design, eligibility criteria, interventions, and outcome measures.
    Difference
    48%
    Check dated 2026-11-09T13:44:56.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:43:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A notice announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.
    Difference
    1%
    Check dated 2026-10-26T14:57:38.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changes from v3.7.1 to v3.7.2, while the page remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-19T14:43:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T14:45:44.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error screen with a 403 header and basic navigation. This replaces the previous study-content that was visible on the page.
    Difference
    18%
    Check dated 2026-09-21T20:28:27.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus FOLFOX in Rectal Cancer Clinical Trial page.